PROCTER & GAMBLE HEALTH | NUTRAPLUS PR | PROCTER & GAMBLE HEALTH/ NUTRAPLUS PR |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -0.1 | - | View Chart |
P/BV | x | 10.6 | 0.3 | 3,186.4% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH NUTRAPLUS PR |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
NUTRAPLUS PR Mar-20 |
PROCTER & GAMBLE HEALTH/ NUTRAPLUS PR |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 22 | 24,511.6% | |
Low | Rs | 3,883 | 5 | 72,444.0% | |
Sales per share (Unadj.) | Rs | 740.7 | 25.6 | 2,891.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | -14.0 | -985.3% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -12.7 | -1,226.5% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 6.3 | 7,060.0% | |
Shares outstanding (eoy) | m | 16.60 | 34.09 | 48.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 0.5 | 1,173.8% | |
Avg P/E ratio | x | 33.5 | -1.0 | -3,444.3% | |
P/CF ratio (eoy) | x | 29.8 | -1.1 | -2,766.9% | |
Price / Book Value ratio | x | 10.3 | 2.1 | 480.7% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 464 | 16,525.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 73 | 2,809.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 873 | 1,407.8% | |
Other income | Rs m | 184 | 1 | 12,860.1% | |
Total revenues | Rs m | 12,480 | 875 | 1,426.6% | |
Gross profit | Rs m | 3,247 | -358 | -906.0% | |
Depreciation | Rs m | 281 | 47 | 597.7% | |
Interest | Rs m | 8 | 74 | 10.4% | |
Profit before tax | Rs m | 3,142 | -478 | -657.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 0 | - | |
Profit after tax | Rs m | 2,295 | -478 | -479.8% | |
Gross profit margin | % | 26.4 | -41.0 | -64.4% | |
Effective tax rate | % | 27.0 | 0 | - | |
Net profit margin | % | 18.7 | -54.8 | -34.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 178 | 6,582.4% | |
Current liabilities | Rs m | 6,791 | 890 | 763.1% | |
Net working cap to sales | % | 40.0 | -81.5 | -49.1% | |
Current ratio | x | 1.7 | 0.2 | 862.5% | |
Inventory Days | Days | 263 | 1 | 40,651.0% | |
Debtors Days | Days | 343 | 11,562,625 | 0.0% | |
Net fixed assets | Rs m | 10,617 | 939 | 1,131.1% | |
Share capital | Rs m | 166 | 170 | 97.4% | |
"Free" reserves | Rs m | 7,265 | 46 | 15,899.5% | |
Net worth | Rs m | 7,431 | 216 | 3,437.8% | |
Long term debt | Rs m | 0 | 2 | 0.0% | |
Total assets | Rs m | 22,330 | 1,117 | 1,999.9% | |
Interest coverage | x | 409.1 | -5.4 | -7,525.9% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.8 | 70.4% | |
Return on assets | % | 10.3 | -36.2 | -28.5% | |
Return on equity | % | 30.9 | -221.3 | -14.0% | |
Return on capital | % | 42.4 | -185.1 | -22.9% | |
Exports to sales | % | 0 | 1.3 | 0.0% | |
Imports to sales | % | 13.1 | 0.7 | 1,904.8% | |
Exports (fob) | Rs m | NA | 11 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 6 | 26,801.3% | |
Fx inflow | Rs m | 1,465 | 11 | 13,012.4% | |
Fx outflow | Rs m | 1,605 | 6 | 26,801.3% | |
Net fx | Rs m | -140 | 5 | -2,660.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 91 | 2,602.0% | |
From Investments | Rs m | -215 | -27 | 800.4% | |
From Financial Activity | Rs m | -985 | -76 | 1,301.3% | |
Net Cashflow | Rs m | 1,160 | -12 | -9,808.1% |
Indian Promoters | % | 0.0 | 40.1 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | 66,566.7% | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 59.9 | 80.4% | |
Shareholders | 56,778 | 7,943 | 714.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | NUTRAPLUS PR | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 5.00% | 0.45% |
1-Month | -1.15% | 9.95% | 2.55% |
1-Year | 0.73% | -60.67% | 56.14% |
3-Year CAGR | -8.76% | -52.30% | 15.22% |
5-Year CAGR | 4.97% | -40.89% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the NUTRAPLUS PR share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of NUTRAPLUS PR the stake stands at 40.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of NUTRAPLUS PR.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
NUTRAPLUS PR paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of NUTRAPLUS PR.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.